NHS England Funds Groundbreaking Gene Therapy for Haemophilia B: A New Dawn for Patients
The UK’s National Health Service (NHS) has once again taken a bold step forward. The recent announcement that NHS England will fund etranacogene dezaparvovec (Hemgenix®), a groundbreaking gene therapy for haemophilia B, has ignited hope for thousands of patients across the nation. This landmark decision marks the first time the NHS has funded a … [Read more…]
